| Particulars (Rupees in Crores.) | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 |
|---|---|---|---|---|---|
Gross Sales | 8,545.2 | 8,506 | 8,358.6 | 8,016.1 | 7,672.7 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8,545.2 | 8,506 | 8,358.6 | 8,016.1 | 7,672.7 |
Other Operating Income | 26.9 | 22.4 | 22.6 | 22.1 | 23.4 |
Other Income | 290.5 | 527.6 | 154.4 | 313.6 | 193.1 |
Total Income | 8,862.6 | 9,056 | 8,535.6 | 8,351.8 | 7,889.2 |
Total Expenditure | 6,398.5 | 6,530.5 | 6,108.2 | 5,961.7 | 5,566.2 |
PBIDT | 2,464.1 | 2,525.5 | 2,427.4 | 2,390.1 | 2,323 |
Interest | 83 | 65.6 | 81.7 | 75.7 | 59.8 |
PBDT | 2,381.1 | 2,459.9 | 2,345.7 | 2,314.4 | 2,263.2 |
Depreciation | 476.1 | 454.7 | 471.4 | 397 | 380.6 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 1,026.1 | 432.3 | 533 | 771.3 | 521.5 |
Deferred Tax | -531 | -13.8 | -62.9 | -195.8 | -31.3 |
Reported Profit After Tax | 1,409.9 | 1,586.7 | 1,404.2 | 1,341.9 | 1,392.4 |
Minority Interest After NP | -8.2 | -6.6 | -9.5 | 86.2 | 0 |
Net Profit after Minority Interest | 1,418.1 | 1,593.3 | 1,413.7 | 1,255.7 | 1,392.4 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 1,418.1 | 1,593.3 | 1,413.7 | 1,255.7 | 1,392.4 |
EPS (Unit Curr.) | 17.04 | 19.12 | 16.97 | 75.4 | 83.61 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 83.5 | 83.4 | 83.4 | 83.4 | 83.4 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 28.83 | 29.69 | 29.04 | 29.81 | 30.27 |
PBDTM(%) | 27.86 | 28.91 | 28.06 | 28.87 | 29.49 |
PATM(%) | 16.49 | 18.65 | 16.79 | 16.74 | 18.14 |
The inspection, conducted between September 4 and September 12, 2025, was a pre-approval review.
Here are some of the stocks that may see significant price movement today: Apollo Hospitals, GMR Airports, RailTel Corporation, etc.
The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.
As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.
Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.
The board has recommended a final dividend of ₹8 per equity share for FY 2024–25
Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
